SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications
Author(s) -
André Jefremow,
Markus F. Neurath
Publication year - 2020
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000513180
Subject(s) - covid-19 , virology , virus , sars virus , gastrointestinal tract , medicine , pandemic , disease , betacoronavirus , intensive care medicine , infectious disease (medical specialty) , outbreak , pathology
Background: About 1 year ago a novel virus – SARS-CoV-2 – began to spread around the world. It can lead to the disease COVID-19, which has caused more than 1 million deaths already. Summary: While it was first recognized as a disease leading to pneumonia and lung failure, we know by now that COVID-19 is more complex. COVID-19 is a systemic hyperinflammatory disease affecting not only the lungs, but also many other organs. Especially the gastrointestinal (GI) tract is often involved in COVID-19. Key Messages: This review provides an overview of the different affected organs of the GI tract and offers information on how gastroenterologists should take care of their patients with different GI disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom